About Leucine Rich Bio
Leucine Rich Bio is a company based in Bengaluru (India) founded in 2014. Leucine Rich Bio has raised $483.8 thousand across 6 funding rounds from investors including Omphalos Ventures, Nitesh Aggarwal and Raghavendra Rao TS. The company has 17 employees as of April 01, 2024. Leucine Rich Bio operates in a competitive market with competitors including Depixus, Synlogic Therapeutics, Trace Genomics, Genomics and Seven Bridges Genomics, among others.
- Headquarter Bengaluru, India
- Employees 17 as on 01 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Leucine Rich Bio Private Limited
- Date of Incorporation 21 Aug, 2014
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$108.3 K (USD)767.88as on Mar 31, 2017
-
Net Profit
$14.61 K (USD)134.7as on Mar 31, 2017
-
EBITDA
-$67.73 K (USD)-74.85as on Mar 31, 2017
-
Total Equity Funding
$483.8 K (USD)
in 6 rounds
-
Latest Funding Round
$59.21 K (USD), Angel Round
Nov 15, 2024
-
Investors
Omphalos Ventures
& 4 more
-
Employee Count
17
as on Apr 01, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Leucine Rich Bio
Leucine Rich Bio has successfully raised a total of $483.8K across 6 strategic funding rounds. The most recent funding activity was a Angel Round of $59.21 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Leucine Rich Bio
Leucine Rich Bio has secured backing from 5 investors, including venture fund and angel investors. Prominent investors backing the company include Omphalos Ventures, Nitesh Aggarwal and Raghavendra Rao TS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made by Omphalos Ventures in US firms.
|
Locked | Locked | Locked | |
|
NA
Nitesh Aggarwal |
-
|
Locked | Locked | Locked |
|
RR
Raghavendra Rao TS |
-
|
Locked | Locked | Locked |
Investor details for Leucine Rich Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Leucine Rich Bio
Investment portfolio details for Leucine Rich Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Leucine Rich Bio
Detailed financials for Leucine Rich Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Leucine Rich Bio Comparisons
Peer comparison for Leucine Rich Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Leucine Rich Bio
Leucine Rich Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Depixus, Synlogic Therapeutics, Trace Genomics, Genomics and Seven Bridges Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Engineered microbes are developed as programmable therapeutics for metabolic disorders.
|
|
| Locked | Locked | Locked |
Developer of technologies to diagnose soil health and soil-borne disease prediction
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
Detailed competitors of Leucine Rich Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Leucine Rich Bio
Complete news archive for Leucine Rich Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leucine Rich Bio
Leucine Rich Bio was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Leucine Rich Bio is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Leucine Rich Bio is a funded company, having raised a total of $483.8K across 6 funding rounds to date.
As of Apr 01, 2024, the latest employee count at Leucine Rich Bio is 17.
Annual revenue of Leucine Rich Bio is $108.3K as on Mar 31, 2017.
Provider of the genomics-based platform to analyze microbiome. The Bugspeaks platform is used to analyze gut microbial sequencing data to provide personalized dietary and supplements recommendations. Other platforms are Metarich that is for cloud-based microbiome analysis, Rychbiome develops probiotics, prebiotics synbiotics based on the microbiome. The company is also developing two programs LRB120305 is formulations for specific diseases and LRB210814 for diagnostics. They provide services in the area of computer science, information science, data management, statistics, and systems biology to solve complex problems in genomics.
Leucine Rich Bio's top competitors include Trace Genomics, Synlogic Therapeutics and Kallyope.
Leucine Rich Bio has 5 investors. Key investors include Omphalos Ventures, Nitesh Aggarwal, Raghavendra Rao TS, Ashwin Porwal, and Snehal Porwal.
The valuation of Leucine Rich Bio is $3.95M as of Sep 2023.